SYF2 suppression mitigates neurodegeneration in models of diverse forms of ALS

Authors:

Abstract
No abstract available
Funding Information
  • Indiana Clinical and Translational Sciences Institute (W81XWH-21-1-0355)
  • ALS Association (22-PDF-588)
  • ALS Association (984923)
  • Office of the Director
  • Universidad de Antioquia
  • University of Southern California
  • Bruno and Ilse Frick Foundation for Research on ALS
  • Donald E. and Delia B. Baxter Foundation
  • U.S. Department of War (W81XWH-21-1-0168)
  • U.S. Department of War (W81XWH-21-1-0131)
  • U.S. Department of War (W81XWH-20-1-0424)
  • U.S. Department of War (W81XWH-15-1-0187)
  • National Heart, Lung, and Blood Institute (UM1 HG006493/U24 HG008956)
  • John Douglas French Alzheimer's Foundation
  • Judith and Jean Adams Charitable Foundation
  • Association for Frontotemporal Degeneration
  • California Institute for Regenerative Medicine (DISC2-12158)
  • National Human Genome Research Institute
  • Muscular Dystrophy Association
  • Alzheimer's Drug Discovery Foundation
  • Tau Consortium
  • Harrington Discovery Institute, University Hospitals
  • National Institutes of Health (S10OD021553)
  • National Institutes of Health (2R01NS097850)
  • National Institutes of Health (R44NS097094)
  • National Institutes of Health (R00NS077435)
  • National Institutes of Health (R01NS131409)
  • New York Stem Cell Foundation
  • University of California, Santa Barbara
  • Center for Mendelian Genomics, University of Washington

This publication has 63 references indexed in Scilit: